Phloretin is reported to down-regulate the secretion of TNF-α in the brain of Aβ25-35-induced AD rats (145), decrease the levels of IL-6, IL-1β, iNOS and COX-2, and reduce activated microglia and astrocytes in the brain from MPTP-induced PD mice (146). This evidence concerns the gene IL1B and Alzheimer disease.